Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?
Identifieur interne : 000989 ( Main/Exploration ); précédent : 000988; suivant : 000990Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?
Auteurs : C G Stevenson [Canada] ; M A Mcarthur ; M. Naus ; E. Abraham ; A J McgeerSource :
- CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [ 0820-3946 ] ; 2001.
Descripteurs français
- KwdFr :
- Adhésion aux directives (), Adhésion aux directives (tendances), Amantadine (usage thérapeutique), Analyse de variance, Antiviraux (usage thérapeutique), Canada (épidémiologie), Enquêtes et questionnaires, Flambées de maladies (), Foyers pour personnes agées, Grippe humaine (), Grippe humaine (épidémiologie), Guides de bonnes pratiques cliniques comme sujet, Humains, Lutte contre l'infection (), Lutte contre l'infection (normes), Lutte contre l'infection (tendances), Modèles logistiques, Personnel de santé (), Pneumonie à pneumocoques (), Pneumonie à pneumocoques (épidémiologie), Santé au travail (), Sujet âgé, Surveillance de la population, Vaccination (), Vaccination (normes), Vaccination (tendances), Établissements de soins qualifiés, Études transversales.
- MESH :
- normes : Lutte contre l'infection, Vaccination.
- tendances : Adhésion aux directives, Lutte contre l'infection, Vaccination.
- usage thérapeutique : Amantadine, Antiviraux.
- épidémiologie : Canada, Grippe humaine, Pneumonie à pneumocoques.
- Adhésion aux directives, Analyse de variance, Enquêtes et questionnaires, Flambées de maladies, Foyers pour personnes agées, Grippe humaine, Guides de bonnes pratiques cliniques comme sujet, Humains, Lutte contre l'infection, Modèles logistiques, Personnel de santé, Pneumonie à pneumocoques, Santé au travail, Sujet âgé, Surveillance de la population, Vaccination, Établissements de soins qualifiés, Études transversales.
- Wicri :
- geographic : Canada.
English descriptors
- KwdEn :
- Aged, Amantadine (therapeutic use), Analysis of Variance, Antiviral Agents (therapeutic use), Canada (epidemiology), Cross-Sectional Studies, Disease Outbreaks (prevention & control), Disease Outbreaks (statistics & numerical data), Guideline Adherence (statistics & numerical data), Guideline Adherence (trends), Health Personnel (statistics & numerical data), Homes for the Aged, Humans, Infection Control (methods), Infection Control (standards), Infection Control (statistics & numerical data), Infection Control (trends), Influenza, Human (epidemiology), Influenza, Human (prevention & control), Logistic Models, Occupational Health (statistics & numerical data), Pneumonia, Pneumococcal (epidemiology), Pneumonia, Pneumococcal (prevention & control), Population Surveillance, Practice Guidelines as Topic, Skilled Nursing Facilities, Surveys and Questionnaires, Vaccination (standards), Vaccination (statistics & numerical data), Vaccination (trends).
- MESH :
- chemical , therapeutic use : Amantadine, Antiviral Agents.
- geographic , epidemiology : Canada.
- epidemiology : Influenza, Human, Pneumonia, Pneumococcal.
- methods : Infection Control.
- prevention & control : Disease Outbreaks, Influenza, Human, Pneumonia, Pneumococcal.
- standards : Infection Control, Vaccination.
- statistics & numerical data : Disease Outbreaks, Guideline Adherence, Health Personnel, Infection Control, Occupational Health, Vaccination.
- trends : Guideline Adherence, Infection Control, Vaccination.
- Aged, Analysis of Variance, Cross-Sectional Studies, Homes for the Aged, Humans, Logistic Models, Population Surveillance, Practice Guidelines as Topic, Skilled Nursing Facilities, Surveys and Questionnaires.
Abstract
BACKGROUND
Influenza and pneumococcal pneumonia are serious health problems among elderly people and a major cause of death in long-term care facilities. We describe the results of serial surveys of vaccination coverage and influenza outbreak management in Canadian long-term care facilities over the last decade.
METHODS
Cross-sectional surveys consisting of questionnaires mailed to all Canadian residential long-term care facilities for elderly people in 1991 and to a random sample of respondents in 1995 and 1999.
RESULTS
The response rates were 83% (430/515) in 1995 and 75% (380/506) in 1999. In 1999 the mean reported rates of influenza vaccination were 83% among residents and 35% among staff, and the mean rate of pneumococcal vaccination among residents was 71%; all 3 rates were significantly higher than those in 1991. The rates were also higher in facilities with an infection control practitioner than in those without such an individual (88% v. 82% for influenza vaccination among residents [p < 0.001], 42% v. 35% for influenza vaccination among staff [p = 0.008] and 75% v. 63% for pneumococcal vaccination among residents [p < 0.001]). Obtaining consent for vaccination on admission to the facility was associated with higher influenza and pneumococcal vaccination rates among residents (p = 0.04 and p < 0.001 respectively). Facilities with higher influenza vaccination rates among residents and staff reported lower rates of influenza outbreaks (p = 0.08 and 0.03 respectively). Despite recommendations from the National Advisory Committee on Immunization, only 50% of the facilities had policies for amantadine prophylaxis during influenza A outbreaks. Amantadine was judged effective in controlling 76% of the influenza A outbreaks and was discontinued because of side effects in 3% of the residents.
INTERPRETATION
Influenza and pneumococcal vaccination rates among residents and staff in Canadian long-term care facilities have increased over the last decade but remain suboptimal. Vaccination of residents and staff against influenza is associated with a reduced risk of influenza outbreaks. Amantadine is effective in controlling influenza outbreaks in long-term care facilities.
PubMed: 11387913
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?</title><author><name sortKey="Stevenson, C G" sort="Stevenson, C G" uniqKey="Stevenson C" first="C G" last="Stevenson">C G Stevenson</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ont.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mcarthur, M A" sort="Mcarthur, M A" uniqKey="Mcarthur M" first="M A" last="Mcarthur">M A Mcarthur</name></author><author><name sortKey="Naus, M" sort="Naus, M" uniqKey="Naus M" first="M" last="Naus">M. Naus</name></author><author><name sortKey="Abraham, E" sort="Abraham, E" uniqKey="Abraham E" first="E" last="Abraham">E. Abraham</name></author><author><name sortKey="Mcgeer, A J" sort="Mcgeer, A J" uniqKey="Mcgeer A" first="A J" last="Mcgeer">A J Mcgeer</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2001">2001</date><idno type="RBID">pubmed:11387913</idno><idno type="pmid">11387913</idno><idno type="wicri:Area/Main/Corpus">000A77</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000A77</idno><idno type="wicri:Area/Main/Curation">000A77</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000A77</idno><idno type="wicri:Area/Main/Exploration">000A77</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?</title><author><name sortKey="Stevenson, C G" sort="Stevenson, C G" uniqKey="Stevenson C" first="C G" last="Stevenson">C G Stevenson</name><affiliation wicri:level="4"><nlm:affiliation>Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ont.</nlm:affiliation><orgName type="university">Université de Toronto</orgName><country>Canada</country><placeName><settlement type="city">Toronto</settlement><region type="state">Ontario</region></placeName></affiliation></author><author><name sortKey="Mcarthur, M A" sort="Mcarthur, M A" uniqKey="Mcarthur M" first="M A" last="Mcarthur">M A Mcarthur</name></author><author><name sortKey="Naus, M" sort="Naus, M" uniqKey="Naus M" first="M" last="Naus">M. Naus</name></author><author><name sortKey="Abraham, E" sort="Abraham, E" uniqKey="Abraham E" first="E" last="Abraham">E. Abraham</name></author><author><name sortKey="Mcgeer, A J" sort="Mcgeer, A J" uniqKey="Mcgeer A" first="A J" last="Mcgeer">A J Mcgeer</name></author></analytic><series><title level="j">CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</title><idno type="ISSN">0820-3946</idno><imprint><date when="2001" type="published">2001</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Amantadine (therapeutic use)</term><term>Analysis of Variance</term><term>Antiviral Agents (therapeutic use)</term><term>Canada (epidemiology)</term><term>Cross-Sectional Studies</term><term>Disease Outbreaks (prevention & control)</term><term>Disease Outbreaks (statistics & numerical data)</term><term>Guideline Adherence (statistics & numerical data)</term><term>Guideline Adherence (trends)</term><term>Health Personnel (statistics & numerical data)</term><term>Homes for the Aged</term><term>Humans</term><term>Infection Control (methods)</term><term>Infection Control (standards)</term><term>Infection Control (statistics & numerical data)</term><term>Infection Control (trends)</term><term>Influenza, Human (epidemiology)</term><term>Influenza, Human (prevention & control)</term><term>Logistic Models</term><term>Occupational Health (statistics & numerical data)</term><term>Pneumonia, Pneumococcal (epidemiology)</term><term>Pneumonia, Pneumococcal (prevention & control)</term><term>Population Surveillance</term><term>Practice Guidelines as Topic</term><term>Skilled Nursing Facilities</term><term>Surveys and Questionnaires</term><term>Vaccination (standards)</term><term>Vaccination (statistics & numerical data)</term><term>Vaccination (trends)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adhésion aux directives ()</term><term>Adhésion aux directives (tendances)</term><term>Amantadine (usage thérapeutique)</term><term>Analyse de variance</term><term>Antiviraux (usage thérapeutique)</term><term>Canada (épidémiologie)</term><term>Enquêtes et questionnaires</term><term>Flambées de maladies ()</term><term>Foyers pour personnes agées</term><term>Grippe humaine ()</term><term>Grippe humaine (épidémiologie)</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Lutte contre l'infection ()</term><term>Lutte contre l'infection (normes)</term><term>Lutte contre l'infection (tendances)</term><term>Modèles logistiques</term><term>Personnel de santé ()</term><term>Pneumonie à pneumocoques ()</term><term>Pneumonie à pneumocoques (épidémiologie)</term><term>Santé au travail ()</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Vaccination ()</term><term>Vaccination (normes)</term><term>Vaccination (tendances)</term><term>Établissements de soins qualifiés</term><term>Études transversales</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Amantadine</term><term>Antiviral Agents</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Canada</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Influenza, Human</term><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Lutte contre l'infection</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Disease Outbreaks</term><term>Influenza, Human</term><term>Pneumonia, Pneumococcal</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Infection Control</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Disease Outbreaks</term><term>Guideline Adherence</term><term>Health Personnel</term><term>Infection Control</term><term>Occupational Health</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Adhésion aux directives</term><term>Lutte contre l'infection</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Guideline Adherence</term><term>Infection Control</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Amantadine</term><term>Antiviraux</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Canada</term><term>Grippe humaine</term><term>Pneumonie à pneumocoques</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Analysis of Variance</term><term>Cross-Sectional Studies</term><term>Homes for the Aged</term><term>Humans</term><term>Logistic Models</term><term>Population Surveillance</term><term>Practice Guidelines as Topic</term><term>Skilled Nursing Facilities</term><term>Surveys and Questionnaires</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adhésion aux directives</term><term>Analyse de variance</term><term>Enquêtes et questionnaires</term><term>Flambées de maladies</term><term>Foyers pour personnes agées</term><term>Grippe humaine</term><term>Guides de bonnes pratiques cliniques comme sujet</term><term>Humains</term><term>Lutte contre l'infection</term><term>Modèles logistiques</term><term>Personnel de santé</term><term>Pneumonie à pneumocoques</term><term>Santé au travail</term><term>Sujet âgé</term><term>Surveillance de la population</term><term>Vaccination</term><term>Établissements de soins qualifiés</term><term>Études transversales</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Canada</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>BACKGROUND</b></p><p>Influenza and pneumococcal pneumonia are serious health problems among elderly people and a major cause of death in long-term care facilities. We describe the results of serial surveys of vaccination coverage and influenza outbreak management in Canadian long-term care facilities over the last decade.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Cross-sectional surveys consisting of questionnaires mailed to all Canadian residential long-term care facilities for elderly people in 1991 and to a random sample of respondents in 1995 and 1999.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The response rates were 83% (430/515) in 1995 and 75% (380/506) in 1999. In 1999 the mean reported rates of influenza vaccination were 83% among residents and 35% among staff, and the mean rate of pneumococcal vaccination among residents was 71%; all 3 rates were significantly higher than those in 1991. The rates were also higher in facilities with an infection control practitioner than in those without such an individual (88% v. 82% for influenza vaccination among residents [p < 0.001], 42% v. 35% for influenza vaccination among staff [p = 0.008] and 75% v. 63% for pneumococcal vaccination among residents [p < 0.001]). Obtaining consent for vaccination on admission to the facility was associated with higher influenza and pneumococcal vaccination rates among residents (p = 0.04 and p < 0.001 respectively). Facilities with higher influenza vaccination rates among residents and staff reported lower rates of influenza outbreaks (p = 0.08 and 0.03 respectively). Despite recommendations from the National Advisory Committee on Immunization, only 50% of the facilities had policies for amantadine prophylaxis during influenza A outbreaks. Amantadine was judged effective in controlling 76% of the influenza A outbreaks and was discontinued because of side effects in 3% of the residents.</p></div><div type="abstract" xml:lang="en"><p><b>INTERPRETATION</b></p><p>Influenza and pneumococcal vaccination rates among residents and staff in Canadian long-term care facilities have increased over the last decade but remain suboptimal. Vaccination of residents and staff against influenza is associated with a reduced risk of influenza outbreaks. Amantadine is effective in controlling influenza outbreaks in long-term care facilities.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">11387913</PMID><DateCompleted><Year>2001</Year><Month>06</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0820-3946</ISSN><JournalIssue CitedMedium="Print"><Volume>164</Volume><Issue>10</Issue><PubDate><Year>2001</Year><Month>May</Month><Day>15</Day></PubDate></JournalIssue><Title>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</Title><ISOAbbreviation>CMAJ</ISOAbbreviation></Journal><ArticleTitle>Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?</ArticleTitle><Pagination><MedlinePgn>1413-9</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Influenza and pneumococcal pneumonia are serious health problems among elderly people and a major cause of death in long-term care facilities. We describe the results of serial surveys of vaccination coverage and influenza outbreak management in Canadian long-term care facilities over the last decade.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Cross-sectional surveys consisting of questionnaires mailed to all Canadian residential long-term care facilities for elderly people in 1991 and to a random sample of respondents in 1995 and 1999.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The response rates were 83% (430/515) in 1995 and 75% (380/506) in 1999. In 1999 the mean reported rates of influenza vaccination were 83% among residents and 35% among staff, and the mean rate of pneumococcal vaccination among residents was 71%; all 3 rates were significantly higher than those in 1991. The rates were also higher in facilities with an infection control practitioner than in those without such an individual (88% v. 82% for influenza vaccination among residents [p < 0.001], 42% v. 35% for influenza vaccination among staff [p = 0.008] and 75% v. 63% for pneumococcal vaccination among residents [p < 0.001]). Obtaining consent for vaccination on admission to the facility was associated with higher influenza and pneumococcal vaccination rates among residents (p = 0.04 and p < 0.001 respectively). Facilities with higher influenza vaccination rates among residents and staff reported lower rates of influenza outbreaks (p = 0.08 and 0.03 respectively). Despite recommendations from the National Advisory Committee on Immunization, only 50% of the facilities had policies for amantadine prophylaxis during influenza A outbreaks. Amantadine was judged effective in controlling 76% of the influenza A outbreaks and was discontinued because of side effects in 3% of the residents.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Influenza and pneumococcal vaccination rates among residents and staff in Canadian long-term care facilities have increased over the last decade but remain suboptimal. Vaccination of residents and staff against influenza is associated with a reduced risk of influenza outbreaks. Amantadine is effective in controlling influenza outbreaks in long-term care facilities.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stevenson</LastName><ForeName>C G</ForeName><Initials>CG</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Mount Sinai Hospital, University of Toronto, Toronto, Ont.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McArthur</LastName><ForeName>M A</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>Naus</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Abraham</LastName><ForeName>E</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>McGeer</LastName><ForeName>A J</ForeName><Initials>AJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Canada</Country><MedlineTA>CMAJ</MedlineTA><NlmUniqueID>9711805</NlmUniqueID><ISSNLinking>0820-3946</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>BF4C9Z1J53</RegistryNumber><NameOfSubstance UI="D000547">Amantadine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>AIM</CitationSubset><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>CMAJ. 2001 May 15;164(10):1447-8</RefSource><PMID Version="1">11387917</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000547" MajorTopicYN="N">Amantadine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000704" MajorTopicYN="N">Analysis of Variance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002170" MajorTopicYN="N" Type="Geographic">Canada</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006282" MajorTopicYN="N">Health Personnel</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006707" MajorTopicYN="Y">Homes for the Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016015" MajorTopicYN="N">Logistic Models</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016272" MajorTopicYN="N">Occupational Health</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011018" MajorTopicYN="N">Pneumonia, Pneumococcal</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017410" MajorTopicYN="N">Practice Guidelines as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012866" MajorTopicYN="Y">Skilled Nursing Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2001</Year><Month>6</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2001</Year><Month>6</Month><Day>29</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2001</Year><Month>6</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">11387913</ArticleId><ArticleId IdType="pmc">PMC81067</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clin Infect Dis. 1998 May;26(5):1117-23</Citation><ArticleIdList><ArticleId IdType="pubmed">9597239</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Lett Drugs Ther. 1999 Sep 10;41(1061):84</Citation><ArticleIdList><ArticleId IdType="pubmed">10505073</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1997 Oct 22-29;278(16):1333-9</Citation><ArticleIdList><ArticleId IdType="pubmed">9343464</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1996 Apr;44(4):349-55</Citation><ArticleIdList><ArticleId IdType="pubmed">8636576</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaccine. 1999 Jun 4;17(20-21):2493-500</Citation><ArticleIdList><ArticleId IdType="pubmed">10418894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Jan 8;355(9198):93-7</Citation><ArticleIdList><ArticleId IdType="pubmed">10675165</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1999 Mar 10;281(10):908-13</Citation><ArticleIdList><ArticleId IdType="pubmed">10078487</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Epidemiol Sante Publique. 1985;33(6):437-44</Citation><ArticleIdList><ArticleId IdType="pubmed">3914014</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1995 Jan;43(1):71-4</Citation><ArticleIdList><ArticleId IdType="pubmed">7806745</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 1997 Dec 1;157(11):1573-6</Citation><ArticleIdList><ArticleId IdType="pubmed">9400415</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1991 Jul;39(7):700-5</Citation><ArticleIdList><ArticleId IdType="pubmed">2061537</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane Database Syst Rev. 2000;(2):CD001169</Citation><ArticleIdList><ArticleId IdType="pubmed">10796612</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Recomm Rep. 1999 Apr 30;48(RR-4):1-28</Citation><ArticleIdList><ArticleId IdType="pubmed">10366138</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 1998 Feb 7;351(9100):399-403</Citation><ArticleIdList><ArticleId IdType="pubmed">9482293</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1986 Nov 20;315(21):1318-27</Citation><ArticleIdList><ArticleId IdType="pubmed">3534568</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1990 Apr;38(4):428-32</Citation><ArticleIdList><ArticleId IdType="pubmed">2329251</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1991 Dec 13;40(49):841-4</Citation><ArticleIdList><ArticleId IdType="pubmed">1961174</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Med. 1997 Oct;103(4):281-90</Citation><ArticleIdList><ArticleId IdType="pubmed">9382120</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 1999 Sep 1;25(17):150-1</Citation><ArticleIdList><ArticleId IdType="pubmed">10513118</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 1995 May;20(5):1371-6</Citation><ArticleIdList><ArticleId IdType="pubmed">7620025</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 1999 Jul;20(7):499-503</Citation><ArticleIdList><ArticleId IdType="pubmed">10432163</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 1999 Jul 14;282(2):137-44</Citation><ArticleIdList><ArticleId IdType="pubmed">10411194</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 1998 Oct 6;159(7):826-7</Citation><ArticleIdList><ArticleId IdType="pubmed">9841108</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1995 Oct 5;333(14):889-93</Citation><ArticleIdList><ArticleId IdType="pubmed">7666874</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1997 Jan;175(1):1-6</Citation><ArticleIdList><ArticleId IdType="pubmed">8985189</ArticleId></ArticleIdList></Reference><Reference><Citation>Med Lett Drugs Ther. 1999 Sep 10;41(1061):82-3</Citation><ArticleIdList><ArticleId IdType="pubmed">10505072</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1996 Oct;44(10):1153-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8855992</ArticleId></ArticleIdList></Reference><Reference><Citation>AAOHN J. 1999 Jul;47(7):301-9</Citation><ArticleIdList><ArticleId IdType="pubmed">10661043</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Jan 8;355(9198):83-4</Citation><ArticleIdList><ArticleId IdType="pubmed">10675161</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 1993 Sep 15;19(17):136-42, 145-7</Citation><ArticleIdList><ArticleId IdType="pubmed">8220294</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 1989 Mar;37(3):210-8</Citation><ArticleIdList><ArticleId IdType="pubmed">2918190</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1994 Dec 12-26;154(23):2666-77</Citation><ArticleIdList><ArticleId IdType="pubmed">7993150</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2000 Mar 4;355(9206):827-35</Citation><ArticleIdList><ArticleId IdType="pubmed">10711940</ArticleId></ArticleIdList></Reference><Reference><Citation>MMWR Morb Mortal Wkly Rep. 1998 Oct 2;47(38):797-802</Citation><ArticleIdList><ArticleId IdType="pubmed">9776166</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 1997 Aug;176 Suppl 1:S56-61</Citation><ArticleIdList><ArticleId IdType="pubmed">9240696</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1995 Nov 27;155(21):2336-40</Citation><ArticleIdList><ArticleId IdType="pubmed">7487259</ArticleId></ArticleIdList></Reference><Reference><Citation>Arch Intern Med. 1988 Apr;148(4):865-8</Citation><ArticleIdList><ArticleId IdType="pubmed">3355306</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Control. 1994 Winter;9(4):109-11</Citation><ArticleIdList><ArticleId IdType="pubmed">7766913</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Control Hosp Epidemiol. 1995 Jan;16(1):18-24</Citation><ArticleIdList><ArticleId IdType="pubmed">7897169</ArticleId></ArticleIdList></Reference><Reference><Citation>Can Commun Dis Rep. 2000 Jun 1;26:1-16</Citation><ArticleIdList><ArticleId IdType="pubmed">10920540</ArticleId></ArticleIdList></Reference><Reference><Citation>Can J Infect Dis. 1991 Fall;2(3):101-8</Citation><ArticleIdList><ArticleId IdType="pubmed">22529718</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country><region><li>Ontario</li></region><settlement><li>Toronto</li></settlement><orgName><li>Université de Toronto</li></orgName></list><tree><noCountry><name sortKey="Abraham, E" sort="Abraham, E" uniqKey="Abraham E" first="E" last="Abraham">E. Abraham</name><name sortKey="Mcarthur, M A" sort="Mcarthur, M A" uniqKey="Mcarthur M" first="M A" last="Mcarthur">M A Mcarthur</name><name sortKey="Mcgeer, A J" sort="Mcgeer, A J" uniqKey="Mcgeer A" first="A J" last="Mcgeer">A J Mcgeer</name><name sortKey="Naus, M" sort="Naus, M" uniqKey="Naus M" first="M" last="Naus">M. Naus</name></noCountry><country name="Canada"><region name="Ontario"><name sortKey="Stevenson, C G" sort="Stevenson, C G" uniqKey="Stevenson C" first="C G" last="Stevenson">C G Stevenson</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/GrippeCanadaV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000989 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000989 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= GrippeCanadaV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:11387913
|texte= Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: how are we doing?
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:11387913" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeCanadaV3
| This area was generated with Dilib version V0.6.35. |  |